• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性景观与分子建模探索双重表观遗传抑制剂的 SAR:以 G9a 和 DNMT1 为重点。

Activity Landscape and Molecular Modeling to Explore the SAR of Dual Epigenetic Inhibitors: A Focus on G9a and DNMT1.

机构信息

Medicinal Chemistry Laboratory, University of Veracruz, Agustín de Iturbide Esq. Carmen Serdan, 91700 Veracruz, Mexico.

Department of Pharmacy, School of Chemistry, National Autonomous University of Mexico, 04510 Mexico City, Mexico.

出版信息

Molecules. 2018 Dec 11;23(12):3282. doi: 10.3390/molecules23123282.

DOI:10.3390/molecules23123282
PMID:30544967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6321328/
Abstract

In this work we discuss the insights from activity landscape, docking and molecular dynamics towards the understanding of the structure-activity relationships of dual inhibitors of major epigenetic targets: lysine methyltransferase (G9a) and DNA methyltranferase 1 (DNMT1). The study was based on a novel data set of 50 published compounds with reported experimental activity for both targets. The activity landscape analysis revealed the presence of activity cliffs, e.g., pairs of compounds with high structure similarity but large activity differences. Activity cliffs were further rationalized at the molecular level by means of molecular docking and dynamics simulations that led to the identification of interactions with key residues involved in the dual activity or selectivity with the epigenetic targets.

摘要

在这项工作中,我们讨论了从活性景观、对接和分子动力学角度对双重表观遗传靶点抑制剂(组蛋白甲基转移酶(G9a)和 DNA 甲基转移酶 1(DNMT1))的结构-活性关系的深入了解。该研究基于 50 种已发表化合物的新型数据集,这些化合物对两种靶点均具有报道的实验活性。活性景观分析揭示了活性悬崖的存在,例如,具有高结构相似性但活性差异较大的化合物对。通过分子对接和动力学模拟进一步从分子水平上对活性悬崖进行了合理化,这些模拟导致了与双重活性或与表观遗传靶点选择性相关的关键残基相互作用的鉴定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/309332461bbf/molecules-23-03282-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/d7a9ecb5a2be/molecules-23-03282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/1bca481046a1/molecules-23-03282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/7abf2a3fd2fb/molecules-23-03282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/6201eca30e99/molecules-23-03282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/6d3fd71d352d/molecules-23-03282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/e7a4e6c9c865/molecules-23-03282-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/26575fb4aae6/molecules-23-03282-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/79dd5ee09df7/molecules-23-03282-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/70a30ad9fdee/molecules-23-03282-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/1da7a0f099d8/molecules-23-03282-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/309332461bbf/molecules-23-03282-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/d7a9ecb5a2be/molecules-23-03282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/1bca481046a1/molecules-23-03282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/7abf2a3fd2fb/molecules-23-03282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/6201eca30e99/molecules-23-03282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/6d3fd71d352d/molecules-23-03282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/e7a4e6c9c865/molecules-23-03282-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/26575fb4aae6/molecules-23-03282-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/79dd5ee09df7/molecules-23-03282-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/70a30ad9fdee/molecules-23-03282-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/1da7a0f099d8/molecules-23-03282-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/6321328/309332461bbf/molecules-23-03282-g011.jpg

相似文献

1
Activity Landscape and Molecular Modeling to Explore the SAR of Dual Epigenetic Inhibitors: A Focus on G9a and DNMT1.活性景观与分子建模探索双重表观遗传抑制剂的 SAR:以 G9a 和 DNMT1 为重点。
Molecules. 2018 Dec 11;23(12):3282. doi: 10.3390/molecules23123282.
2
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.旨在理解 G9a 抑制剂的活性:一种活性图谱和分子建模方法。
J Comput Aided Mol Des. 2020 Jun;34(6):659-669. doi: 10.1007/s10822-020-00298-x. Epub 2020 Feb 14.
3
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.深入探索 4-氨基喹啉化学空间,以探索赖氨酸甲基转移酶 G9a 和 DNA 甲基转移酶的生物学空间。
J Med Chem. 2018 Aug 9;61(15):6546-6573. doi: 10.1021/acs.jmedchem.7b01925. Epub 2018 Jul 19.
4
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.双重靶向 G9a 和 DNA 甲基转移酶 1 治疗实验性胆管癌。
Hepatology. 2021 Jun;73(6):2380-2396. doi: 10.1002/hep.31642.
5
Computational Methods for Epigenetic Drug Discovery: A Focus on Activity Landscape Modeling.计算方法在表观遗传药物发现中的应用:以活性景观建模为重点。
Adv Protein Chem Struct Biol. 2018;113:65-83. doi: 10.1016/bs.apcsb.2018.01.001. Epub 2018 Mar 5.
6
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.组蛋白甲基转移酶 G9a 和 DNA 甲基转移酶 1 的双重靶向治疗实验性肝细胞癌。
Hepatology. 2019 Feb;69(2):587-603. doi: 10.1002/hep.30168. Epub 2019 Jan 4.
7
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Efficacy in Multiple Myeloma.新型组蛋白去乙酰化酶、DNA 甲基转移酶 1 和赖氨酸甲基转移酶 G9a 表观遗传抑制剂的设计与合成及其在多发性骨髓瘤中的疗效。
J Med Chem. 2021 Mar 25;64(6):3392-3426. doi: 10.1021/acs.jmedchem.0c02255. Epub 2021 Mar 4.
8
Discovery, design and synthesis of 6H-anthra[1,9-cd]isoxazol-6-one scaffold as G9a inhibitor through a combination of shape-based virtual screening and structure-based molecular modification.通过基于形状的虚拟筛选和基于结构的分子修饰相结合的方法,发现、设计并合成6H-蒽[1,9-cd]异恶唑-6-酮支架作为G9a抑制剂。
Bioorg Med Chem. 2016 Nov 15;24(22):6102-6108. doi: 10.1016/j.bmc.2016.09.071. Epub 2016 Sep 30.
9
Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.迈向基于化学信息学的DNA甲基转移酶抑制剂鉴定:筛选文库的二维和三维相似性概况
Curr Comput Aided Drug Des. 2012 Dec 1;8(4):317-29. doi: 10.2174/157340912803519606.
10
Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.新型组蛋白赖氨酸甲基转移酶 G9a/GLP(EHMT2/1)抑制剂的发现:2,4-二氨基-6-甲基嘧啶的设计、合成及构效关系。
Bioorg Med Chem Lett. 2020 Oct 15;30(20):127475. doi: 10.1016/j.bmcl.2020.127475. Epub 2020 Aug 8.

引用本文的文献

1
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.G9a:神经退行性疾病的一种表观遗传治疗策略——从靶点发现到临床试验
Med Res Rev. 2025 May;45(3):985-1015. doi: 10.1002/med.22096. Epub 2025 Jan 6.
2
De Novo Design of Inhibitors of DNA Methyltransferase 1: A Critical Comparison of Ligand- and Structure-Based Approaches.从头设计 DNA 甲基转移酶 1 抑制剂:配体和基于结构方法的关键比较。
Biomolecules. 2024 Jun 28;14(7):775. doi: 10.3390/biom14070775.
3
Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study.

本文引用的文献

1
Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: a molecular dynamics study.通过底物和抑制剂结合模式分析描绘 G9a 赖氨酸甲基转移酶的活性位点结构:分子动力学研究。
J Biomol Struct Dyn. 2019 Jul;37(10):2581-2592. doi: 10.1080/07391102.2018.1491422. Epub 2018 Nov 17.
2
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.深入探索 4-氨基喹啉化学空间,以探索赖氨酸甲基转移酶 G9a 和 DNA 甲基转移酶的生物学空间。
J Med Chem. 2018 Aug 9;61(15):6546-6573. doi: 10.1021/acs.jmedchem.7b01925. Epub 2018 Jul 19.
3
鉴定表皮生长因子受体和 AKT 的双重靶标抑制剂:基于结构和分子动力学研究的虚拟筛选。
Molecules. 2023 Nov 15;28(22):7607. doi: 10.3390/molecules28227607.
4
Diversity and Chemical Space Characterization of Inhibitors of the Epigenetic Target G9a: A Chemoinformatics Approach.表观遗传靶点G9a抑制剂的多样性与化学空间表征:一种化学信息学方法
ACS Omega. 2023 Aug 11;8(33):30694-30704. doi: 10.1021/acsomega.3c04566. eCollection 2023 Aug 22.
5
Towards Arginase Inhibition: Hybrid SAR Protocol for Property Mapping of Chlorinated -arylcinnamamides.迈向精氨酸酶抑制:用于氯化芳基肉桂酰胺性质图谱绘制的混合构效关系协议
Int J Mol Sci. 2023 Feb 10;24(4):3611. doi: 10.3390/ijms24043611.
6
Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives.新型四环喹喔啉并苯并噻嗪衍生物的设计、合成与抗菌性能。
Int J Mol Sci. 2022 Dec 1;23(23):15078. doi: 10.3390/ijms232315078.
7
7-Aminoalkoxy-Quinazolines from Epigenetic Focused Libraries Are Potent and Selective Inhibitors of DNA Methyltransferase 1.基于表观遗传学靶点文库的 7-烷氧基喹唑啉类化合物是 DNA 甲基转移酶 1 的高效和选择性抑制剂。
Molecules. 2022 Apr 30;27(9):2892. doi: 10.3390/molecules27092892.
8
Towards Property Profiling: SYNTHESIS and SAR Probing of New Tetracyclic Diazaphenothiazine Analogues.朝向属性剖析:新型四环二氮杂苯并噻嗪类似物的合成和 SAR 研究。
Int J Mol Sci. 2021 Nov 26;22(23):12826. doi: 10.3390/ijms222312826.
9
Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.新型乙酰胆碱酯酶抑制剂的合成及混合 SAR 性质建模。
Int J Mol Sci. 2021 Mar 26;22(7):3444. doi: 10.3390/ijms22073444.
10
Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.新型 3-碳硼烷-1,8-萘酰亚胺衍生物的设计、合成与评价及其作为潜在抗癌剂的研究。
Int J Mol Sci. 2021 Mar 9;22(5):2772. doi: 10.3390/ijms22052772.
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously.
同时针对癌症表观遗传学和血管生成的新型帕唑帕尼为基础的 HDAC 和 VEGFR 双重抑制剂的发现。
J Med Chem. 2018 Jun 28;61(12):5304-5322. doi: 10.1021/acs.jmedchem.8b00384. Epub 2018 Jun 7.
4
Insights from pharmacological similarity of epigenetic targets in epipolypharmacology.表型药理学中表观遗传靶点的药理学相似性研究进展
Drug Discov Today. 2018 Jan;23(1):141-150. doi: 10.1016/j.drudis.2017.10.006. Epub 2017 Oct 14.
5
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.同时靶向癌症代谢和表观遗传学的小分子抑制剂:新型烟酰胺磷酸核糖基转移酶(NAMPT)和组蛋白去乙酰化酶(HDAC)双重抑制剂的发现
J Med Chem. 2017 Oct 12;60(19):7965-7983. doi: 10.1021/acs.jmedchem.7b00467. Epub 2017 Sep 21.
6
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.发现针对血液系统恶性肿瘤的 G9a 和 DNMTs 的首创可逆双小分子抑制剂。
Nat Commun. 2017 May 26;8:15424. doi: 10.1038/ncomms15424.
7
Activity Landscape Plotter: A Web-Based Application for the Analysis of Structure-Activity Relationships.活性景观绘图器:一种用于分析结构-活性关系的基于网络的应用程序。
J Chem Inf Model. 2017 Mar 27;57(3):397-402. doi: 10.1021/acs.jcim.6b00776. Epub 2017 Mar 2.
8
Activity cliffs and activity cliff generators based on chemotype-related activity landscapes.基于与化学型相关的活性景观的活性悬崖和活性悬崖生成器。
Mol Divers. 2015 Nov;19(4):1021-35. doi: 10.1007/s11030-015-9609-z. Epub 2015 Jul 7.
9
DataWarrior: an open-source program for chemistry aware data visualization and analysis.DataWarrior:一款用于化学感知数据可视化与分析的开源程序。
J Chem Inf Model. 2015 Feb 23;55(2):460-73. doi: 10.1021/ci500588j. Epub 2015 Feb 2.
10
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.双激酶-溴结构域抑制剂用于合理设计的多药理学。
Nat Chem Biol. 2014 Apr;10(4):305-12. doi: 10.1038/nchembio.1471. Epub 2014 Mar 2.